Ana gezinime atla Aramaya atla Ana içeriğe atla

Pharmacogenetic testing in psychiatry: Perspective on clinical utility

  • Frances Adiukwu
  • , Olufisayo Adesokun
  • , Emmanuel Essien
  • , Nadir Yalcin
  • , Ramdas Ransing
  • , Sachin Nagendrappa
  • , Chonnakarn Jatchavala
  • , Ayotunde Bolatito Olakunke
  • , Faisal A. Nawaz
  • , Nagina Khan
  • University of Port Harcourt
  • University of Calabar
  • Ministry of Health and Family Welfare
  • St. John's National Academy of Health Sciences
  • Prince of Songkla University
  • University of Ilorin
  • Al Amal Psychiatric Hospital
  • University of Oxford

Araştırma sonucu: Dergiye katkıMakalebilirkişi

6 Alıntılar (Scopus)

Özet

Pharmacogenetic studies the influence of inherited characteristics on medication. While different from pharmacogenomics, which is a study of the entire genome in relation to medication effect, their distinction remains inconsistent, and the two terms are used interchangeably. Although the potential of pharmacogenomics in psychiatry is apparent and its clinical utility is suboptimal, the uptake of recommendations and guidelines is minimal and research into PGx is not diverse. This article offers an overview of pharmacogenetics (PGx) in psychiatry, explores the difficulties, and provides recommendations on improving its applicability and clinical utility.

Orijinal dilİngilizce
Makale numarası103674
DergiAsian Journal of Psychiatry
Hacim86
DOI'lar
Yayın durumuYayınlandı - Ağu 2023

BM SKH

Bu sonuç, aşağıdaki Sürdürülebilir Kalkınma Hedefine/Hedeflerine katkıda bulunur

  1. SKH 3 - Sağlık ve Kaliteli Yaşam
    SKH 3 Sağlık ve Kaliteli Yaşam

Parmak izi

Pharmacogenetic testing in psychiatry: Perspective on clinical utility' araştırma başlıklarına git. Birlikte benzersiz bir parmak izi oluştururlar.

Bundan alıntı yap